Minor Label Changes and Approval of Once Weekly Version of Drug Are Anticipated The increasing incidence of obesity has ushered in a ripe market for type 2 diabetes drugs. The commercial landscape is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results